AzTrials
AzTrials

Vital Sign EvaluationANNE One TMRCTNCT06995742

Effect of ANNE One-Wellue Device Array Use on Staff Bedside Vital Sign Measurement Activity

A study testing Device Array Use and Routine Vital Sign Measurement in people with Vital Sign Evaluation and Vital Sign Monitoring, run by Northwestern University at 2 sites in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Randomized controlled trial of a time motion study of time spent obtaining and charting vital signs for inpatients, comparing use of a wireless Bluetooth vital sign array as intervention versus routine vital sign obtainment activity on a general medical floor. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Device Array Use and Routine Vital Sign Measurement
Could I receive a placebo?
No, everyone receives an active treatment
How many people
270 participants
Where
2 sitesUnited States
Study dates
2 Jun 2025to 31 Jul 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Inpatients admitted to Northwestern Memorial Hospital, Feinberg Unit 16 West.

Who cannot join

  • Primary language other than English, under isolation status, pregnant patients, prisoners, employees or students of the hospital or Northwestern University.

Trial locations and contacts

2 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Gregory (Randy) R Smith Jr, MD MS contact

312-926-5893

g.smith@nm.org

Jane S Kim, MS MEd contact

312-926-7272

jane.kim@northwestern.edu

United States2 sites, 2 recruiting
  • Feinberg 16 West, Northwestern Memorial Hospital

    Chicago, Illinois, 60611

    Gregory R Smith Jr, MD MS, 312-926-5893, g.smith@nm.org

    Gregory R Smith Jr, MD MS

    Recruiting
  • Northwestern Memorial Hospital

    Chicago, Illinois, 60611

    Gregory (Randy) R Smith Jr, MD MS, 312-926-5893, g.smith@nm.org

    Not yet recruiting

Other trials in United States

About this study

Official title: Effect of ANNE One-Wellue Device Array Use on Staff Bedside Vital Sign Measurement Activity: A Randomized Controlled Trial

Randomized controlled trial of a time motion study of time spent obtaining and charting vital signs for inpatients, comparing use of a wireless Bluetooth vital sign array as intervention versus routine vital sign obtainment activity on a general medical floor.

Being tested
Device Array Use, Routine Vital Sign Measurement
Keywords
time motion study, vital signs, sleep quality, inpatient sleep, wireless device, patient satisfaction
Medical subject headings
Sleep Initiation and Maintenance Disorders, Patient Satisfaction

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Device Array UseDevice

    Study participants assigned to the intervention study arm will wear a wireless Bluetooth capable vital sign detection array, with one device externally worn on each of their chest, one finger, and one arm, with healthcare providers using an additional oral temperature probe.

  • Routine Vital Sign MeasurementDevice

    Study participants randomized to the control arm will have their vital signs obtained by routine means, without use of the wireless vital sign device array.

Study groups in NCT06995742
Study groupRoleWhat they receive
Intervention--Device Array UseExperimentalInpatients will wear the ANNE One device array for obtainment of vital sign assessments.
Receives: Device: Device Array Use
Control--Routine Vital Sign ObtainmentActive comparatorInpatients will have vital signs determined by routine practice, using any other standard of care-accepted method or device.
Receives: Device: Routine Vital Sign Measurement

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Time Motion Assessment of Time Spent Obtaining and Recording Vital Signs

    The number of seconds spent by a healthcare provider obtaining and charting vital signs will be witnessed and recorded by a research staff member.

    Measured: Number of seconds spent obtaining and charting vital signs is obtained at 8a daily, for maximum of three days for each study participant, and are added together to equal the total time spent on vital sign assessment.

Secondary outcomes (3)
  1. Sleep Quality of Inpatient Study Participants

    Sleep quality will be determined by use of the Potential Hospital Sleep Disruptions and Noises Questionnaire survey, administered to study participants after a night of study enrolment. The survey scores sleep quality from 1 to 5 with 1 signifying no disruption and 5 signifying extreme disruption.

    Measured: Survey conducted 24-72 hours after enrolment.

  2. Patient Satisfaction with Inpatient Sleep Quality

    Question 8, "During this hospital stay, how often were you able to get the rest you needed?" of the Hospital Consumer Assessment of Healthcare Providers and Systems post-discharge questionnaire will be collected for study participants. Survey responses include: never, sometimes, usually, always.

    Measured: Survey sent within a week of hospital discharge and collected within the subsequent thirty days.

  3. Healthcare Provider Experience with the Vital Sign Device Array

    Healthcare providers who use the device array will be surveyed with a Technology Acceptance Method survey to assess usability of the device array.

    Measured: The electronic survey will be administered twice during the study. Each survey will take approximately ten minutes to complete.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 May 2025
  2. Study start2 Jun 2025
  3. Primary completion31 Jul 2026 (estimated)
  4. Study completion31 Jul 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Model description
Randomized Controlled Trial
Masking
None (open label)
Enrolment
270 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06995742
Sponsor's protocol ID
STU00219340
Other IDs
2023 Dixon Translational Grant
Acronym
ANNE One TMRCT
Status last verified
Jun 2025
First submitted
29 Apr 2025
Last updated
5 Jun 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Device Array Use and Routine Vital Sign Measurement in people with Vital Sign Evaluation and Vital Sign Monitoring, run by Northwestern University at 2 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 5 Jun 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Gregory (Randy) R Smith Jr, MD MS (312-926-5893, g.smith@nm.org), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Time Motion Assessment of Time Spent Obtaining and Recording Vital Signs (time frame: Number of seconds spent obtaining and charting vital signs is obtained at 8a daily, for maximum of three days for each study participant, and are added together to equal the total time spent on vital sign assessment.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Jun 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in